AAG
ABBV icon

Armstrong Advisory Group’s AbbVie ABBV Stock Holding History

Armstrong Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.69M Buy
10,276
+1,083
+12% +$278K 0.16% 49
2026
Q2 		$2.31M Sell
9,193
-72
-0.8% -$15.5K 0.14% 56
2026
Q1 		$2.02M Sell
9,265
-150
-2% -$33.3K 0.14% 57
2025
Q4 		$2.15M Sell
9,415
-75
-0.8% -$17.1K 0.15% 54
2025
Q3 		$2.2M Buy
9,490
+10
+0.1% +$2.04K 0.16% 52
2025
Q2 		$1.76M Sell
9,480
-362
-4% -$67.3K 0.13% 53
2025
Q1 		$1.75M Hold
9,842
– – 0.14% 49
2024
Q4 		$1.75M Buy
9,842
+58
+0.6% +$10.7K 0.14% 49
2024
Q3 		$1.93M Sell
9,784
-49
-0.5% -$9.14K 0.16% 44
2024
Q2 		$1.69M Sell
9,833
-386
-4% -$63.9K 0.15% 43
2024
Q1 		$1.58M Hold
10,219
– – 0.15% 42
2023
Q4 		$1.58M Sell
10,219
-189
-2% -$27.6K 0.15% 42
2023
Q3 		$1.55M Buy
10,408
+105
+1% +$15.4K 0.17% 39
2023
Q2 		$1.39M Sell
10,303
-705
-6% -$103K 0.15% 42
2023
Q1 		$1.75M Sell
11,008
-218
-2% -$33.3K 0.21% 36
2022
Q4 		$1.81M Buy
+11,226
New +$1.72M 0.24% 42

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Armstrong Advisory Group's ABBV Position: Q3 2026 in Review

Armstrong Advisory Group increased its AbbVie (ABBV) stake by 12% in Q3 2026, buying an estimated $278K and bringing the position to 10,276 shares worth $2.69M. The position accounts for 0.16% of the portfolio, ranked #49.

Armstrong Advisory Group first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Armstrong Advisory Group held 10,276 shares of AbbVie worth $2.69M as of Q3 2026.
  • Armstrong Advisory Group bought 1,083 AbbVie shares in Q3 2026, an estimated $278K.
  • AbbVie made up 0.16% of Armstrong Advisory Group's portfolio in Q3 2026, its #49 holding.
  • Armstrong Advisory Group first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.